162 related articles for article (PubMed ID: 34431085)
1. Epstein-Barr virus (EBV) deletions as biomarkers of response to treatment of chronic active EBV.
Venturini C; Houldcroft CJ; Lazareva A; Wegner F; Morfopoulou S; Amrolia PJ; Golwala Z; Rao A; Marks SD; Simmonds J; Yoshikawa T; Farrell PJ; Cohen JI; Worth AJ; Breuer J
Br J Haematol; 2021 Oct; 195(2):249-255. PubMed ID: 34431085
[TBL] [Abstract][Full Text] [Related]
2. Sintilimab treatment for chronic active Epstein-Barr virus infection and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children.
Chen R; Lin Q; Zhu Y; Shen Y; Xu Q; Tang H; Cui N; Jiang L; Dai X; Chen W; Li X
Orphanet J Rare Dis; 2023 Sep; 18(1):297. PubMed ID: 37736751
[TBL] [Abstract][Full Text] [Related]
3. Chronic active Epstein-Barr virus infection manifesting as coronary artery aneurysm and uveitis.
Xiao H; Hu B; Luo R; Hu H; Zhang J; Kuang W; Zhang R; Li L; Liu G
Virol J; 2020 Oct; 17(1):166. PubMed ID: 33121509
[TBL] [Abstract][Full Text] [Related]
4. [Significance of detecting the EBV-DNA level in peripheral blood mononuclear cells and the EBV-infected cell type in patients with chronic active EBV infection].
Xing Y; Song HM; Wu XY; Wang W; Wei M
Zhonghua Er Ke Za Zhi; 2011 Jul; 49(7):495-500. PubMed ID: 22088177
[TBL] [Abstract][Full Text] [Related]
5. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States.
Cohen JI; Jaffe ES; Dale JK; Pittaluga S; Heslop HE; Rooney CM; Gottschalk S; Bollard CM; Rao VK; Marques A; Burbelo PD; Turk SP; Fulton R; Wayne AS; Little RF; Cairo MS; El-Mallawany NK; Fowler D; Sportes C; Bishop MR; Wilson W; Straus SE
Blood; 2011 Jun; 117(22):5835-49. PubMed ID: 21454450
[TBL] [Abstract][Full Text] [Related]
6. Plasma viral microRNA profiles reveal potential biomarkers for chronic active Epstein-Barr virus infection.
Kawano Y; Iwata S; Kawada J; Gotoh K; Suzuki M; Torii Y; Kojima S; Kimura H; Ito Y
J Infect Dis; 2013 Sep; 208(5):771-9. PubMed ID: 23687223
[TBL] [Abstract][Full Text] [Related]
7. Chronic active Epstein-Barr virus infection of T-cell type, systemic form in an African migrant: case report and review of the literature on diagnostics standards and therapeutic options.
Wass M; Bauer M; Pfannes R; Lorenz K; Odparlik A; Müller LP; Wickenhauser C
BMC Cancer; 2018 Oct; 18(1):941. PubMed ID: 30285657
[TBL] [Abstract][Full Text] [Related]
8. Quantification of Epstein-Barr virus DNA is helpful for evaluation of chronic active Epstein-Barr virus infection.
Sakamoto Y; Mariya Y; Kubo K
Tohoku J Exp Med; 2012 Aug; 227(4):307-11. PubMed ID: 22850617
[TBL] [Abstract][Full Text] [Related]
9. Defective Epstein-Barr virus in chronic active infection and haematological malignancy.
Okuno Y; Murata T; Sato Y; Muramatsu H; Ito Y; Watanabe T; Okuno T; Murakami N; Yoshida K; Sawada A; Inoue M; Kawa K; Seto M; Ohshima K; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Narita Y; Yoshida M; Goshima F; Kawada JI; Nishida T; Kiyoi H; Kato S; Nakamura S; Morishima S; Yoshikawa T; Fujiwara S; Shimizu N; Isobe Y; Noguchi M; Kikuta A; Iwatsuki K; Takahashi Y; Kojima S; Ogawa S; Kimura H
Nat Microbiol; 2019 Mar; 4(3):404-413. PubMed ID: 30664667
[TBL] [Abstract][Full Text] [Related]
10. Interferon alpha as antiviral therapy in chronic active Epstein-Barr virus disease with interstitial pneumonia - case report.
Roliński J; Grywalska E; Pyzik A; Dzik M; Opoka-Winiarska V; Surdacka A; Maj M; Burdan F; Pirożyński M; Grabarczyk P; Starosławska E
BMC Infect Dis; 2018 Apr; 18(1):190. PubMed ID: 29678144
[TBL] [Abstract][Full Text] [Related]
11. Updated guidelines for chronic active Epstein-Barr virus disease.
Kawada JI; Ito Y; Ohshima K; Yamada M; Kataoka S; Muramatsu H; Sawada A; Wada T; Imadome KI; Arai A; Iwatsuki K; Ohga S; Kimura H;
Int J Hematol; 2023 Nov; 118(5):568-576. PubMed ID: 37728704
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic values for the viral load in peripheral blood mononuclear cells of patients with chronic active Epstein-Barr virus disease.
Ito Y; Suzuki M; Kawada J; Kimura H
J Infect Chemother; 2016 Apr; 22(4):268-71. PubMed ID: 26712582
[TBL] [Abstract][Full Text] [Related]
13. [The road to treating chronic active Epstein-Barr viral infection].
Arai A
Rinsho Ketsueki; 2021; 62(7):835-845. PubMed ID: 34349069
[TBL] [Abstract][Full Text] [Related]
14. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection.
Kasahara Y; Yachie A; Takei K; Kanegane C; Okada K; Ohta K; Seki H; Igarashi N; Maruhashi K; Katayama K; Katoh E; Terao G; Sakiyama Y; Koizumi S
Blood; 2001 Sep; 98(6):1882-8. PubMed ID: 11535525
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous, restricted patterns of Epstein-Barr virus (EBV) latent gene expression in patients with chronic active EBV infection.
Yoshioka M; Ishiguro N; Ishiko H; Ma X; Kikuta H; Kobayashi K
J Gen Virol; 2001 Oct; 82(Pt 10):2385-2392. PubMed ID: 11562532
[TBL] [Abstract][Full Text] [Related]
16. Chronic active Epstein-Barr virus disease originates from infected hematopoietic stem cells.
Wang J; Su M; Wei N; Yan H; Zhang J; Gong Y; Wu L; Suolitiken D; Pi Y; Song D; Chen L; Liu H; Yang S; Wang X; Wang Z
Blood; 2024 Jan; 143(1):32-41. PubMed ID: 37824804
[TBL] [Abstract][Full Text] [Related]
17. Successful control of Epstein-Barr virus (EBV)-infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection.
Uehara T; Nakaseko C; Hara S; Harima A; Ejiri M; Yokota A; Saito Y; Nishimura M
Am J Hematol; 2004 Aug; 76(4):368-72. PubMed ID: 15282671
[TBL] [Abstract][Full Text] [Related]
18. Unique Epstein-Barr virus (EBV) latent gene expression, EBNA promoter usage and EBNA promoter methylation status in chronic active EBV infection.
Yoshioka M; Kikuta H; Ishiguro N; Ma X; Kobayashi K
J Gen Virol; 2003 May; 84(Pt 5):1133-1140. PubMed ID: 12692278
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive assessment of peripheral blood TCRβ repertoire in infectious mononucleosis and chronic active EBV infection patients.
Liu S; Zhang Q; Huang D; Zhang W; Zhong F; Feng J; Chen X; Meng Q; Chen X; Zhang W; Zhang H
Ann Hematol; 2017 Apr; 96(4):665-680. PubMed ID: 28091735
[TBL] [Abstract][Full Text] [Related]
20. Late-onset posttransplant Epstein-Barr virusrelated lymphoproliferative disease after cord blood transplantation for chronic active Epstein Barr virus infection: A case report.
Yamamoto M; Shindo M; Funayama T; Sumi C; Saito T; Toki Y; Hatayama M; Imadome KI; Mizukami Y; Okumura T
Medicine (Baltimore); 2022 Mar; 101(12):e29055. PubMed ID: 35357349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
